Junteng Zhou

646 total citations
24 papers, 471 citations indexed

About

Junteng Zhou is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Junteng Zhou has authored 24 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cancer Research. Recurrent topics in Junteng Zhou's work include Adenosine and Purinergic Signaling (4 papers), Cancer-related molecular mechanisms research (4 papers) and Mitochondrial Function and Pathology (3 papers). Junteng Zhou is often cited by papers focused on Adenosine and Purinergic Signaling (4 papers), Cancer-related molecular mechanisms research (4 papers) and Mitochondrial Function and Pathology (3 papers). Junteng Zhou collaborates with scholars based in China, Sweden and Mexico. Junteng Zhou's co-authors include Xiaojing Liu, Geer Tian, Yanguo Xin, Wenchao Wu, Junli Li, Yong Tang, Zhichao Zhou, Decai Chen, Haiyan Yin and Xin Cao and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Pharmacological Research.

In The Last Decade

Junteng Zhou

23 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junteng Zhou China 12 268 84 77 57 51 24 471
Junsuk Ko United States 13 269 1.0× 105 1.3× 67 0.9× 137 2.4× 57 1.1× 18 661
Daniel J. Herr United States 16 307 1.1× 133 1.6× 36 0.5× 69 1.2× 47 0.9× 41 701
Bingqing Deng China 15 306 1.1× 156 1.9× 71 0.9× 68 1.2× 91 1.8× 42 642
Huiyi Jin China 12 244 0.9× 33 0.4× 82 1.1× 72 1.3× 41 0.8× 24 594
Xinyang Hu China 11 260 1.0× 99 1.2× 55 0.7× 90 1.6× 105 2.1× 34 564
Byung‐Hyun Park South Korea 14 206 0.8× 42 0.5× 99 1.3× 38 0.7× 114 2.2× 15 531
Kensuke Sasaki Japan 16 398 1.5× 42 0.5× 56 0.7× 55 1.0× 137 2.7× 53 881
Shiyue Xu China 15 267 1.0× 125 1.5× 62 0.8× 100 1.8× 57 1.1× 24 457
Jiangtao Yan China 12 159 0.6× 90 1.1× 58 0.8× 64 1.1× 66 1.3× 23 460
Dan Lan China 13 253 0.9× 46 0.5× 111 1.4× 54 0.9× 42 0.8× 42 640

Countries citing papers authored by Junteng Zhou

Since Specialization
Citations

This map shows the geographic impact of Junteng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junteng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junteng Zhou more than expected).

Fields of papers citing papers by Junteng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junteng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junteng Zhou. The network helps show where Junteng Zhou may publish in the future.

Co-authorship network of co-authors of Junteng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Junteng Zhou. A scholar is included among the top collaborators of Junteng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junteng Zhou. Junteng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Junteng, et al.. (2025). CD4+ T Cell Subsets and PTPN22 as Novel Biomarkers of Immune Dysregulation in Dilated Cardiomyopathy. International Journal of Molecular Sciences. 26(16). 7806–7806. 1 indexed citations
3.
Zhou, Junteng, et al.. (2025). U-shaped association between myeloperoxidase levels and anxiety risk: a cross-sectional study in a Chinese population. Frontiers in Public Health. 13. 1596844–1596844.
4.
Zhou, Junteng, Geer Tian, Fang‐Yang Huang, et al.. (2023). The long noncoding RNA THBS1-AS1 promotes cardiac fibroblast activation in cardiac fibrosis by regulating TGFBR1. JCI Insight. 8(6). 17 indexed citations
5.
Tian, Geer, Junteng Zhou, Junli Li, et al.. (2023). Voltage-dependent anion channel 1 (VDAC1) overexpression alleviates cardiac fibroblast activation in cardiac fibrosis via regulating fatty acid metabolism. Redox Biology. 67. 102907–102907. 15 indexed citations
6.
Zhou, Junteng, Chi Ma, Yan Chen, et al.. (2023). Inhibition of long noncoding RNA Gm41724 alleviates pressure overload-induced cardiac fibrosis by regulating lamina-associated polypeptide 2α. Pharmacological Research. 188. 106677–106677. 6 indexed citations
7.
Zhang, Shuwen, et al.. (2022). The Role of Bile Acids in Cardiovascular Diseases: from Mechanisms to Clinical Implications. Aging and Disease. 14(2). 0–0. 23 indexed citations
8.
Zhou, Junteng, Ruicen Li, Ting Bao, Wei Jiang, & Yan Huang. (2022). Association between serum 25-hydroxyvitamin d and myeloperoxidase: A cross-sectional study of a general population in China. Frontiers in Nutrition. 9. 948691–948691. 3 indexed citations
9.
Chen, Yan, et al.. (2022). Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis. Frontiers in Pharmacology. 13. 940768–940768. 13 indexed citations
10.
Tian, Geer, et al.. (2021). Purinergic P2 Receptors: Novel Mediators of Mechanotransduction. Frontiers in Pharmacology. 12. 671809–671809. 11 indexed citations
11.
Zhou, Junteng, Zhichao Zhou, Xiaojing Liu, et al.. (2021). P2X7 Receptor–Mediated Inflammation in Cardiovascular Disease. Frontiers in Pharmacology. 12. 654425–654425. 37 indexed citations
12.
Tian, Geer, et al.. (2021). P2Y1 Receptor Agonist Attenuates Cardiac Fibroblasts Activation Triggered by TGF-β1. Frontiers in Pharmacology. 12. 627773–627773. 11 indexed citations
13.
Zhou, Junteng, et al.. (2021). [The potential role of long non-coding RNA Dnm3os in the activation of cardiac fibroblasts].. PubMed. 38(3). 574–582. 4 indexed citations
14.
Zhou, Junteng, Qin Wang, Chunyan Lu, et al.. (2020). <p>Association Between Bone Mineral Density and Lipid Profile in Chinese Women</p>. Clinical Interventions in Aging. Volume 15. 1649–1664. 48 indexed citations
15.
Zhou, Junteng, et al.. (2020). New indices of arterial stiffness correlate with disease severity and mid-term prognosis in acute decompensated heart failure. Internal and Emergency Medicine. 16(3). 661–668. 4 indexed citations
16.
Xin, Yanguo, et al.. (2020). Mitochondrial ROS-Modulated mtDNA: A Potential Target for Cardiac Aging. Oxidative Medicine and Cellular Longevity. 2020. 1–11. 168 indexed citations
17.
Tian, Geer, Junteng Zhou, Xiaojing Liu, & Yong‐Can Huang. (2019). Mechanoresponse of stem cells for vascular repair. World Journal of Stem Cells. 11(12). 1104–1114. 11 indexed citations
18.
Zhou, Junteng, et al.. (2017). The effect and safety of diacerein in patients with type 2 diabetes mellitus : a systematic review and meta-analysis.. PubMed. 6(6). 97–106. 7 indexed citations
19.
Zhou, Junteng, et al.. (2017). The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis. Postgraduate Medicine. 130(1). 129–136. 7 indexed citations
20.
Lu, Daru, et al.. (1993). Stage I clinical trial of gene therapy for hemophilia B.. PubMed. 36(11). 1342–51. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026